High Flow Nasal Oxygen (HFNO) in acute respiratory failure
High flow nasal oxygen (HFNO) is a relatively recent respiratory support technique that delivers high flow, heated and humidified controlled concentration of oxygen via the nasal route. Recently, its use has increased for a variety of clinical indications.
This free webinar, on 29 April, delineated the use and benefits of HFNO in acute respiratory failure, including:
• Clinical practice guidelines
• Ventilation strategies in patients with COVID-19 severe pneumonia
• Perioperative use of HFNO
Prof Bram ROCHWERG – Intensivist and researcher, McMaster University, Hamilton (CA). Executive, Canadian Critical Care Society, Internal Medicine Section at the Society of Critical Care Medicine and The Canadian Critical Care Trials Group.
Prof Sheila MYATRA – Consultant Critical Care Specialist, Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Mumbai (IN). Secretary, Indian College of Critical Care Medicine of the Indian Society of Critical Care Medicine (ISCCM).
Prof Samir JABER – Head of the Critical Care and Anesthesia Department of Saint-Eloi University Hospital, Montpellier (FR). Full “exceptional class” (highest degree) professor in Anesthesiology and Critical Care, Faculty of Medicine of Montpellier. Senior Deputy Editor of the ICM Journal.
Prof Sharon EINAV – Director of Surgical Intensive Care & Chair of the Resuscitation Committee Shaare Zedek Medical Center, Jerusalem (IL). Professor of Anaesthesia and Intensive Care Hebrew University Faculty of Medicine, Jerusalem, (IL). Chair, ESICM Systematic Review Group.
Dr Jean-Pierre FRAT – Intensivist and researcher, Poitiers University Hospital (FR). Chief investigator of the FLORALI study and researcher in the ALIVE team (Acute Lung Injury and VENtilatory support) of the Inserm-CIC 1402 unit, Poitiers University Hospital.
Thanks to the support of